BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Huang R, Wang Y, Rao H, Wei L, Su GL, Lok AS. Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis. Hepatol Commun 2019;3:1585-97. [PMID: 31832569 DOI: 10.1002/hep4.1435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Nobarani S, Alaei-Shahmiri F, Aghili R, Malek M, Poustchi H, Lahouti M, Khamseh ME. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes. Dig Dis Sci 2021. [PMID: 33788095 DOI: 10.1007/s10620-021-06953-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Nachit M, De Rudder M, Thissen JP, Schakman O, Bouzin C, Horsmans Y, Vande Velde G, Leclercq IA. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models. J Cachexia Sarcopenia Muscle 2021;12:144-58. [PMID: 33244884 DOI: 10.1002/jcsm.12646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhang W, Su GL, Sravanthi K, Huang R, Wang Y, Rao H, Wei L, Lok AS. Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease. JGH Open. [DOI: 10.1002/jgh3.12756] [Reference Citation Analysis]